Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05927519

Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study

Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, perioperative hemodynamic variables, and postoperative complications will also be recorded.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Obesity, Morbid Body Weight Congenital, Hereditary, and Neonatal Diseases and Abnormalities Endocrine Gland Neoplasms Endocrine System Diseases Genetic Diseases, Inborn Intubation; Difficult or Failed Men Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia Type 1 Neoplasms Neoplasms by Site Neoplasms, Multiple Primary Neoplastic Syndromes, Hereditary Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms Video Laryngoscope

Age range

18 year–80 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Kocaeli University Medical Faculty Hospital, Iamit, Turkey (Türkiye)

Loading trial locations.

About this study

Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, need of optimization menuvers, perioperative hemodynamic variables, and postoperative complications will also be recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

> 18 age men gender elective operation requring intuabtion -

Exclusion criteria

<18 age women emergency operation

-

Treatment and study plan

airtraq video laryngoscope

Device

airtraq video laryngoscope will be used for intubations

Primary outcomes

  1. intubation time

    Time frame: 50 seconds

    the intubation time will be recorded beginning the insertion of the Airtraq through the mouth still the endotracheal tube seen passing through the vocal cords

Secondary outcomes

  1. insertion time

    Time frame: 20 seconds

    inserting the Airtraq through the mouth till the optimal glottic vizualization occurred

  2. peroperative hemodynamic variable

    Time frame: 4 hours

    heart rate

Study contacts

Contact information is provided by the study sponsor or research team.

Zehra Arslan, professor

CONTACT

[email protected]

00902623038168

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Registry information

Official study title

Airtraq in Obese and Nonobese Men

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jul 3, 2023
Registry last updated
Oct 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.